论文部分内容阅读
目的比较七氟醚与丙泊酚在小儿疝气手术中的应用效果。方法选取2013年1月-2014年2月在该院就诊并接受手术治疗的小儿疝气患者72例,结合患儿入院时间先后分为观察组和对照组各36例。观察组给予七氟醚联合骶管麻醉,对照组给予丙泊酚联合骶管麻醉,观察2组患者麻醉效果,统计2组患者手术过程中麻醉不良反应情况。结果 2组患儿手术时间、苏醒时间比较差异无统计学意义(P>0.05),观察组患儿手术过程中出现躁动1例,术后无恶心呕吐症状,不良反应发生率为2.8%(1/36);对照组患儿手术过程中躁动1例,术后恶心呕吐1例,不良反应发生率为5.6%(2/36)。2组患儿均未出现术中痉挛、术后屏气、呛咳等不良反应,2组患儿不良反应发生率对比差异无统计学意义(P>0.05)。2组患儿麻醉后心率、MAP及Sp O2三项生命体征指标水平均低于麻醉前,差异均有统计学意义(P<0.05),但2组患儿麻醉后心率、MAP及Sp O2水平比较差异无统计学意义(P>0.05)。结论七氟醚与丙泊酚在小儿疝气手术中均有着良好的应用效果,患儿恢复时间快并且安全性高,值得临床推广。
Objective To compare the effect of sevoflurane and propofol in pediatric hernia surgery. Methods Seventy-two children with hernia admitted to our hospital from January 2013 to February 2014 were enrolled in this study and 36 cases were divided into observation group and control group respectively. The observation group was given sevoflurane combined with caudal anesthesia. The control group was given propofol combined with caudal anesthesia. The anesthetic effect was observed in two groups. The adverse reactions of anesthesia in the two groups were statistically analyzed. Results There was no significant difference between the two groups in the operation time and recovery time (P> 0.05). One case of agitation was observed in the observation group during operation, and the incidence of nausea and vomiting was 2.8% (1) / 36). In the control group, 1 patient was agitated during operation, 1 patient had nausea and vomiting after operation. The incidence of adverse reactions was 5.6% (2/36). There was no intraoperative spasm, breath holding, cough and other adverse reactions in both groups. There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). The heart rate, MAP and Sp O2 in the two groups were lower than those before anesthesia, the difference was statistically significant (P <0.05), but the heart rate, MAP and Sp O2 levels The difference was not statistically significant (P> 0.05). Conclusions Both sevoflurane and propofol have a good application effect in pediatric hernia surgery. The recovery time and safety of children are safe and worthy of clinical promotion.